Early Initiation of Anticoagulation Improves the Long-Term Prognosis in Patients With Antiphospholipid Syndrome Associated Portal Vein Thrombosis
Objectives: Portal vein thrombosis (PVT) is a rare and severe clinical phenotype of antiphospholipid syndrome (APS) with a poor prognosis. Anticoagulation therapy is efficient but is associated with potentially severe bleeding episodes, especially for those patients with thrombocytopenia. We conduct...
Main Authors: | Hanxiao You, Jiuliang Zhao, Can Huang, Xinping Tian, Mengtao Li, Xiaofeng Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.630660/full |
Similar Items
-
Antiphospholipid Syndrome as a Cause of Recurrent Portal Vein Thrombosis in a Man with a Medical History of other Thrombosis
by: R. G. Sayfutdinov, et al.
Published: (2023-05-01) -
Safety, efficacy and prognosis of anticoagulant therapy for portal vein thrombosis in cirrhosis: a retrospective cohort study
by: Zhiqi Zhang, et al.
Published: (2023-01-01) -
The Effect of Anticoagulant in Patients with Cirrhosis Associated with Acute Portal Vein Thrombosis
by: Hoon Gil Jo, et al.
Published: (2021-09-01) -
Portal vein thrombosis in cirrhosis: A literature review
by: Swathi Prakash, et al.
Published: (2023-04-01) -
Portal Vein Thrombosis: State-of-the-Art Review
by: Andrea Boccatonda, et al.
Published: (2024-03-01)